We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > RA drug

News List

FDA approves COVACTA trial for RA drug Actemra in COVID-19 patients pharmaceutical-business-review
March 25, 2020
Genentech has secured approval in the US to go ahead with the COVACTA trial to assess the use of its rheumatoid arthritis drug (RA drug) Actemra (tocilizumab) in COVID-19 patients.
Which of the Blockbuster Drugs on the Autoimmune Drug Market Will Show the Glory that Humira Had?(4) Siyi
June 11, 2018
TNFα inhibitors have been occupying most of the rheumatoid arthritis (RA) drug market owing to their quick acting clinically...
FDA advisory panel votes against approval of Johnson & Johnson's experimental RA drug Plivensia firstwordpharma
August 03, 2017
Johnson & Johnson announced Wednesday that an FDA advisory panel voted against recommending approval of its experimental rheumatoid arthritis (RA) therapy Plivensia (sirukumab). Citing safety concerns, the panel voted 12 to 1 that the benefits of the drug